Group 1 - The company, Guichuang Tongqiao, repurchased 50,000 shares at an average price of HKD 19.68 per share, totaling approximately HKD 984,000, with a cumulative repurchase of 3.6945 million shares this year, representing 1.16% of the total share capital [1][3] - As of the market close on the same day, Guichuang Tongqiao's stock price decreased by 0.2%, closing at HKD 19.82 per share [2] - The stock repurchase may indicate the company's confidence in its future development, signaling to the market that it believes its shares are undervalued, which can help stabilize the stock price and enhance investor confidence [3] Group 2 - Guichuang Tongqiao is an innovative medical device company listed on the Hong Kong Stock Exchange, focusing on the research, development, production, and sales of neurovascular and peripheral vascular intervention medical devices [4] - The company possesses a range of innovative technologies and product pipelines aimed at providing effective treatment solutions for patients with cardiovascular diseases [4] - Guichuang Tongqiao is committed to exploring innovation within the medical device industry, actively investing in research and development to continuously update its products and meet market demands [4]
归创通桥回购5.00万股股票,共耗资约98.40万港元,本年累计回购369.45万股
Jin Rong Jie·2025-07-10 11:21